Mesenchymal stem cells prevent hypertrophic scar formation via inflammatory regulation when undergoing apoptosis

Journal of Investigative Dermatology

Volumn 134, Issue 10, 2014, Pages 2648-2657

  Liu, Shiyu ^a   Jiang, Lan ^a,b   Li, Haijian ^a,b   Shi, Haigang ^a   Luo, Hailang ^a,c   Zhang, Yongjie ^a,c   Yu, Chunyan ^b   Jin, Yan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c Institute for Tissue Engineering and Regenerative Medicine Research of Xi'an   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CD3 ANTIGEN; CD45 ANTIGEN; HYDROGEN PEROXIDE; PROTEIN; TUMOR NECROSIS ALPHA STIMULATED GENE PROTEIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; TNFAIP6 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL SURVIVAL; CELL THERAPY; CELLULAR SECRETION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERTROPHIC SCAR; INFLAMMATION; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SCAR FORMATION; SKIN INJURY; ANIMAL; CELL CULTURE; CICATRIX, HYPERTROPHIC; FEMALE; IN VITRO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RABBIT; SKIN; WOUND HEALING;

ANIMALS; APOPTOSIS; CASPASE 3; CELL ADHESION MOLECULES; CELLS, CULTURED; CICATRIX, HYPERTROPHIC; FEMALE; HUMANS; IN VITRO TECHNIQUES; INFLAMMATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MODELS, ANIMAL; RABBITS; SKIN; WOUND HEALING;

EID: 84922394675     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.169     Document Type: Article

References (53)

1. Aarabi S, Longaker MT, Gurtner GC (2007) Hypertrophic scar formation following burns and trauma: new approaches to treatment. PLoS Med 4:e234
2. Akiyama K, Chen C, Wang D et al. (2012) Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell 10:544-55
3. Altman AM, Matthias N, Yan Y et al. (2008) Dermal matrix as a carrier for in vivo delivery of human adipose-derived stem cells. Biomaterials 29:1431-42
4. Bergmann A, Steller H (2010) Apoptosis, stem cells, and tissue regeneration. Sci Signal 3:re8
5. Bonini C, Ferrari G, Verzeletti S et al. (1997) HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276:1719-24
6. Boo L, Selvaratnam L, Tai CC et al. (2011) Expansion and preservation of multipotentiality of rabbit bone-marrow derived mesenchymal stem cells in dextran-based microcarrier spin culture. J Mater Sci Mater Med 22:1343-56
7. Caplan AI (2009) Why are MSCs therapeutic? new data: new insight. J Pathol 217:318-24
8. Choi H, Lee RH, Bazhanov N et al. (2011) Anti-inflammatory protein secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kappaB signaling in resident macrophages. Blood 118:330-8
9. Di Stasi A, Tey SK, Dotti G et al. (2011) Inducible apoptosis as a safety switch for adoptive cell therapy. N Engl J Med 365:1673-83
10. Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495-516
11. English K, French A, Wood KJ (2010) Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell 7:431-42
12. Fan H, Zhao G, Liu L et al. (2012) Pre-treatment with IL-1beta enhances the efficacy of MSC transplantation in DSS-induced colitis. Cell Mol Immunol 9:473-81
13. Ferguson MW, O'Kane S (2004) Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 359:839-50
14. Ferreira AM, Takagawa S, Fresco R et al. (2006) Diminished induction of skin fibrosis in mice with MCP-1 deficiency. J Invest Dermatol 126:1900-8
15. Getting SJ, Mahoney DJ, Cao T et al. (2002) The link module from human TSG-6 inhibits neutrophil migration in a hyaluronan-and inter-alpha-inhibitorindependent manner. J Biol Chem 277:51068-76
16. Gieling RG, Wallace K, Han YP (2009) Interleukin-1 participates in the progression from liver injury to fibrosis. Am J Physiol Gastrointest Liver Physiol 296:G1324-31
17. Gurtner GC, Werner S, Barrandon Y et al. (2008) Wound repair and regeneration. Nature 453:314-21
18. Herberts CA, Kwa MS, Hermsen HP (2011) Risk factors in the development of stem cell therapy. J Transl Med 9:29
19. Huang CY, Hagar KL, Frost LE et al. (2004) Effects of cyclic compressive loading on chondrogenesis of rabbit bone-marrow derived mesenchymal stem cells. Stem Cells 22:313-23
20. Jung KH, Song SU, Yi T et al. (2011) Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats. Gastroenterology 140:998-1008
21. Kirkton RD, Bursac N (2008) Genetic engineering and stem cells: combinatorial approaches for cardiac cell therapy. IEEE Eng Med Biol Mag 27:85-8
22. Kloeters O, Tandara A, Mustoe TA (2007) Hypertrophic scar model in the rabbit ear: a reproducible model for studying scar tissue behavior with new observations on silicone gel sheeting for scar reduction. Wound Repair Regen 15(Suppl 1):S40-5
23. Larson BJ, Longaker MT, Lorenz HP (2010) Scarless fetal wound healing: a basic science review. Plast Reconstr Surg 126:1172-80
24. Le Blanc K, Mougiakakos D (2012) Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol 12:383-96
25. Lee RH, Pulin AA, Seo MJ et al. (2009) Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5:54-63
26. Li P, Liu P, Xiong R-P et al. (2011) Ski, a modulator of wound healing and scar formation in the rat skin and rabbit ear. J Pathol 223:659-71
27. Liang Q, Liu S, Han P et al. (2012) Micronized acellular dermal matrix as an efficient expansion substrate and delivery vehicle of adipose-derived stem cells for vocal fold regeneration. Laryngoscope 122:1815-25
28. Liechty KW, MacKenzie TC, Shaaban AF et al. (2000) Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6:1282-6
29. Liu S, Zhang H, Zhang X et al. (2011) Synergistic angiogenesis promoting effects of extracellular matrix scaffolds and adipose-derived stem cells during wound repair. Tissue Eng Part A 17:725-39
30. Milner CM, Higman VA, Day AJ (2006) TSG-6: a pluripotent inflammatory mediator? Biochem Soc Trans 34:446-50
31. Mora-Lee S, Sirerol-Piquer MS, Gutierrez-Perez M et al. (2012) Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice. PLoS One 7:e43683
32. Nemeth K, Leelahavanichkul A, Yuen PS et al. (2009) Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15:42-9
33. Niemeyer P, Szalay K, Luginbuhl R et al. (2010) Transplantation of human mesenchymal stem cells in a non-autogenous setting for bone regeneration in a rabbit critical-size defect model. Acta Biomater 6:900-8
34. Ortiz LA, Dutreil M, Fattman C et al. (2007) Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 104:11002-7
35. Peranteau WH, Zhang L, Muvarak N et al. (2008) IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. J Invest Dermatol 128:1852-60
36. Polchert D, Sobinsky J, Douglas G et al. (2008) IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol 38:1745-55
37. Prasad VK, Lucas KG, Kleiner GI et al. (2011) Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. Biol Blood Marrow Transplant 17:534-41
38. Prockop DJ, Oh JY (2012) Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther 20:14-20
39. Qi Y, Jiang D, Sindrilaru A et al. (2014) TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine full-thickness skin wounds. J Invest Dermatol 134:526-37
40. Reinecke H, Zhang M, Bartosek T et al. (1999) Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 100:193-202
41. Ren G, Chen X, Dong F et al. (2012) Concise review: mesenchymal stem cells and translational medicine: emerging issues. Stem Cells Transl Med 1: 51-8
42. Roddy GW, Oh JY, Lee RH et al. (2011) Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-alpha stimulated gene/protein 6. Stem Cells 29:1572-9
43. Rosova I, Dao M, Capoccia B et al. (2008) Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26:2173-82
44. Ryan JM, Barry FP, Murphy JM et al. (2005) Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2:8
45. Satish L, Kathju S (2010) Cellular and molecular characteristics of scarless versus fibrotic wound healing. Dermatol Res Pract 2010:790234
46. Shi Y, Su J, Roberts AI et al. (2012) How mesenchymal stem cells interact with tissue immune responses. Trends Immunol 33:136-43
47. Smith RE, Strieter RM, Phan SH et al. (1998) TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury. J Leukoc Biol 64:528-36
48. Szpaderska AM, Zuckerman JD, DiPietro LA (2003) Differential injury responses in oral mucosal and cutaneous wounds. J Dent Res 82:621-6
49. Tang L, Li N, Xie H et al. (2011) Characterization of mesenchymal stem cells from human normal and hyperplastic gingiva. J Cell Physiol 226:832-42
50. Tiberghien P, Reynolds CW, Keller J et al. (1994) Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood 84:1333-41
51. Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726-36
52. van der Veer WM, Bloemen MCT, Ulrich MMW et al. (2009) Potential cellular and molecular causes of hypertrophic scar formation. Burns 35:15-29
53. Walther W, Stein U (2000) Viral vectors for gene transfer: a review of their use in the treatment of human diseases. Drugs 60:249-71